Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.

Three female cockle-pickers with baskets, at the coast © Reproduction rights owned by National Library of Ireland

Eleven new research projects have been announced today by the Irish Research Council and the Arts and Humanities Research Council (AHRC), part of UK Research and Innovation (UKRI), that will see the UK and Ireland bring together world-leading expertise in the Digital Humanities.  

Dr Samantha Vanderslott, University of Oxford; Dr Claas Kirchhelle; University College Dublin - Typhoid, Cockles, and Terrorism: The turbulent history of Anglo-Irish typhoid control in revolutionary Dublin  

The project aims to explore the intimate connection between imperial and revolutionary public health politics in 20th century Dublin. The researchers will conduct innovative research on the (post)colonial politics of Anglo-Irish public health and typhoid control in Dublin. They will design a major blended physical/digital exhibition (hosted at Dublin City Library and Archive and the Royal College of Physicians in Ireland), educational resources and create an open access database of spatially coded historical disease, environmental, and infrastructural data. The project will use a mix of historical and digital humanities methods to analyse and digitise historical disease data, medical correspondence, cultural ephemera, infrastructural records, and meteorological data to understand why British bacteriological and sanitary interventions proved impractical in Dublin and how they were perceived by local populations. It hopes to make significant contributions to research and engage audiences from all age groups on the importance of equitable access to effective sanitary infrastructure and vaccines. 

Similar stories

Oxford-led newborn screening pilot expanded to include all babies in England

Every newborn baby in England will be screened for spinal muscular atrophy (SMA), following the expansion of a pioneering University of Oxford-led pilot that introduced the country’s first routine test for the condition.

A New Era for Childhood Cancer Research: Professor Isidro Cortés Ciriano Appointed as Oxford's First Little Princess Trust Professor of Paediatric Oncology

The Department of Paediatrics at the University of Oxford has appointed Professor Isidro Cortés-Ciriano as its first Little Princess Trust Professor of Paediatric Oncology, marking a major milestone in a partnership dedicated to accelerating the development of new treatments for children with cancer.

Oxford University and King’s College London Join IMPACT Network Study to Advance Understanding of Profound Autism

The University of Oxford and King’s College London (King’s) have joined the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international collaboration of sites working together to accelerate clinical trial readiness and therapeutic development for autism through a large-scale natural history and clinical endpoint study.

Scientists in the Department of Paediatrics discover antibody combinations that block over 90% of malaria parasite growth

In an important discovery for the next-generation of malaria vaccines, University of Oxford researchers in the Department of Paediatrics, in collaboration with the Scripps Institute, have identified how antibodies can be over 90% effective at preventing malaria parasites from growing in certain combinations.

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.

Breakthrough study moves newborn screening for SMA towards nationwide rollout

A major national study led by researchers in the Department of Paediatrics, to evaluate newborn screening for spinal muscular atrophy (SMA) has been funded by the National Institute for Health and Care Research (NIHR), marking a significant milestone towards the potential introduction of SMA screening across the UK.